Home
 /
Papers
 /
Neuroscience
 /
A Brainwide Atlas of Synaptic Nanoarchitecture Across the Mouse Lifespan
Preprint
Open access
V1
Top 1% · Validated by QED

A Brainwide Atlas of Synaptic Nanoarchitecture Across the Mouse Lifespan

Takeshi Kaizuka, Zhen Qiu, Edita Bulovaite +8 more
February 2026
 ·
bioRxiv
 ·
DOI 
10.64898/2026.02.18.706606
94
%
Reproducible
QED Impressions
This paper passed independent validation.
QED's automated review checked the evidence supporting each claim, the statistical methods, and whether the results are reproducible from the data provided.

It ranks in the top 1% of preprints assessed in Neuroscience this quarter.
Run full QED analysis
Read paper
Save

Why this is interesting

NanoSYNMAP transforms FRET into a brain-wide, single-synapse proximity metric, delivering the first nanoarchitecture atlas of the synaptome and establishing that supercomplex packing—not just molecular composition—is a fundamental organizing principle of synaptic diversity.

QED claims analysis

Summary

Postsynaptic MAGUK scaffold supercomplexes exhibit nanometer-scale proximity that varies systematically across brain regions, undergoes dynamic remodeling during postnatal development and aging, and is governed by competitive interactions among different MAGUK family members, with genetic disruption of individual scaffolds triggering brain-wide reorganization of this nanoscale architecture that links to synaptic stability and neuropsychiatric disease risk.

See full analysis
Main Claim 1 –

NanoSYNMAP Maps Brainwide Nanoscale Synaptic Protein Proximity

Supporting evidence

  • NanoSYNMAP FRET Reports Inter-Supercomplex, Not Intra-Supercomplex Proximity
Main Claim 2 –

MAGUK Supercomplexes Achieve Nanometer-Scale Proximity Within Synapses

Supporting evidence

  • Synapses Show Broad Distributions of Supercomplex Proximity Indices
Main Claim 3 –

Brain Regions Spatially Pattern Synapses With Distinct Nanoarchitectures

Supporting evidence

  • Protein Abundance and Nanodomain Clustering Increase Supercomplex Proximity
  • SAP102 Competitively Reduces PSD95 Supercomplex Proximity
Main Claim 4 –

Nanoscale Synaptome Architecture Remodels During Development and Aging

Supporting evidence

  • Postnatal PSD95 Proximity Is High Independent of PSD95 Abundance

Abstract

How biological complexity emerges from the ordered assembly of molecular building blocks into supramolecular systems remains a central question, particularly in the mammalian brain with its vast synaptic diversity. We introduce NanoSYNMAP, a genetic, optical, and computational platform that integrates FRET with synaptome mapping to quantify nanoscale proximity of proteins in individual synapses brain-wide. We generate the first brain atlas of synaptic nanoarchitecture, based on the proximity of postsynaptic MAGUK supercomplexes. This reveals a molecular logic in which spacing of supramolecular assemblies specifies nanoscale architecture that organizes the global synaptome architecture. Nanoarchitecture varies across brain regions, differentiates during postnatal development, and remodels with aging. Supercomplex proximity reflects scaffold abundance, nanodomain organization, and competitive interactions among MAGUK assemblies. Deletion of a neuropsychiatric risk gene triggers widespread reorganization of nanoscale architecture. These findings establish molecular proximity as a fundamental scalable dimension of synapse diversity in health and disease.

Related papers

How the QED Score works

QED Score is a validated AI-based quality metric that evaluates life science papers on two dimensions: originality and validity. Each manuscript is anonymized, broken down into its claims and supporting evidence, and examined by specialized AI agents for statistical rigor, consistency across figures, and fit with the existing literature. Scores are percentile ranks, so they're comparable across fields. In blinded tests, expert professors sided with QED Score over journal rank in 75% of decisive cases.
Read the methodology

Free access for academic researchers

Create your free QED account to validate your research, strengthen grant proposals, and uncover scientific insights.
We've sent you an access link.
Please check your inbox.

Didn't get your email? Check your spam folder or reach out to info@qedscience.com

Oops! Something went wrong while submitting the form.
Looking for QED for pharma, biotech or life science organizations?